Literature DB >> 2723111

Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.

A el-Yazigi1, K Chaleby, C R Martin.   

Abstract

The authors examined acetylator phenotypes of 296 Saudi subjects of Arabic origin by measuring the molar concentration ratio of two caffeine metabolites, 5-acetylamino-6-formylamino-3-methyluracil (AFMU) and 1-methylxanthine (1MX), using a simplified version of a previously reported high-performance liquid chromatographic method. Spot urine samples were collected from the subjects who regularly drink coffee, tea, or other caffeinated beverages. The subjects were originally from different regions of Saudi Arabia but currently live primarily in the capital city of Riyadh. The day-to-day reproducibility of the molar concentration ratio of AFMU/1MX was established in 14 randomly selected subjects. These metabolites were stable in urine at 4 degrees and -20 degrees, but AFMU was unstable at room temperature (23 degrees). The frequency distribution data indicate that 72.3% of the subjects are of slow acetylator phenotype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723111     DOI: 10.1002/j.1552-4604.1989.tb03321.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  3 in total

1.  N-acetylation phenotyping using dapsone in a Jordanian population.

Authors:  Y M Irshaid; H F al-Hadidi; M A Abuirjeie; N M Rawashdeh
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

2.  Acetylation phenotype variation in pediatric patients with atopic dermatitis.

Authors:  Rafi A Majeed Al-Razzuqi; Ali A Al-Jeboori; Makram M Al-Waiz
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

3.  Isoniazid acetylation phenotypes in the Sudanese population; findings and implications.

Authors:  Monadil H Ali; Alian A Alrasheedy; Dan Kibuule; Mohamed Azmi Hassali; Brian Godman; Mohammed F Abdelwahab; Raef Y Abbadi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.